- cafead   Jul 31, 2024 at 10:42: AM
via Diamyd Medical has announced that the independent Data Safety Monitoring Board (DSMB) recommended the continuation of the Phase III DIAGNODE-3 trial of Diamyd for type 1 diabetes (T1D) without modifications.
article source
article source